World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 October 2023
Main ID:  JPRN-UMIN000008266
Date of registration: 01/07/2012
Prospective Registration: Yes
Primary sponsor: Department of Orthopaedics, Osaka University Graduate School of Medicine
Public title: Transplantation of a scaffold-free tissue engineered construct (TEC) derived from autologous synovial mesenchymal stem cells for cartilage repair
Scientific title: Transplantation of a scaffold-free tissue engineered construct (TEC) derived from autologous synovial mesenchymal stem cells for cartilage repair - Transplantation of a scaffold-free tissue engineered construct (TEC) for cartilage repair
Date of first enrolment: 2012/09/01
Target sample size: 6
Recruitment status: Complete: follow-up complete
URL:  https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009672
Study type:  Interventional
Study design:  Single arm Non-randomized  
Phase:  Phase II,III
Countries of recruitment
Japan
Contacts
Name: Hideki    Yoshikawa
Address:  2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan Japan
Telephone: 06-6879-3552
Email: yhideki@ort.med.osaka-u.ac.jp
Affiliation:  Osaka University Graduate School of Medicine Department of Orthopaedics
Name: Norimasa    Nakamura
Address:  2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan 565-0871 Japan
Telephone: 06-6879-3552
Email: n-nakamura@ort.med.osaka-u.ac.jp
Affiliation:  Osaka University Center for Advanced Medical Engineering and Infomatics
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: Patients with 1) Active local infection 2) Serious complications including malignancies 3) Alchol or drung abuse 4) Rheumatoid arthritis, gout, or pseudo gout 5) Abnormal alignment of lower extremity 6) Patello-femoral instability 7) Diabetes 8) Renal failure which requires dialysis 9) Infectious disease (HIV, HBV, HCV, HTLV, syphilis) 10) Pregnancy 11) the medication of corticosteroids 12) participation in other clinical trials 13)Judged inappropriate with other reason by the project investigators.

Age minimum: 20years-old
Age maximum: 60years-old
Gender: Male and Female
Health Condition(s) or Problem(s) studied
traumatic chondral injury of the knee joint
Intervention(s)
Implantation of a scaffold-free tissue engineered construct (TEC) derived from autologus synovial mesenchymal stem cell (MSC) for cartilage repair.
Primary Outcome(s)
<Adverse events> presense or absence, pattern, severity, incidence and retention time of adverse events
Secondary Outcome(s)
Periodical assesement of clnical symptoms, evaluatetion by MRI, histology, activity scales (Lyshom, Tegnar), and by overall subjective assessment score (Knee Injury and Osteoarthritis Outcome Score, KOOS). Arthoscopic assessment of repaired tissue using ICRS evaluation package.
Secondary ID(s)
Source(s) of Monetary Support
Health Labour Sciences Research Grant
Secondary Sponsor(s)
Osaka University Hospital, Medical Center for Translational Research
Ethics review
Status: YES
Approval date: 02/05/2012
Contact:
irb-jimu@hp-mctr.med.osaka-u.ac.jp
Osaka University Clinical Research Review Committee
06-6879-6551
irb-jimu@hp-mctr.med.osaka-u.ac.jp
Results
Results available: Yes
Date Posted: 02/07/2020
Date Completed: 30/04/2016
URL: https://journals.sagepub.com/doi/full/10.1177/0363546518781825
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history